Clinical Trial Update: Efficacy and Safety of AJU-C52 in Essential Hypertension Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of AJU-C52 for essential hypertension, with recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• AJU-C52

Snippet

Sponsor: AJU Pharm Co., Ltd. | Conditions: Essential Hypertension | Phase 3 | Status: RECRUITING